T Susanna Meijer

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Venues

Annals of surgical oncology

Cardiovascular and interventional radiology

PloS one

This page only lists publications with an associated author ORCID identifier.

Publications

T Susanna Meijer, Jan H N Dieters, Eleonora M de Leede, Lioe-Fee De Geus-Oei, Jaap Vuijk, Christian H Martini, Arian R van Erkel, Jacob Lutjeboer, Rutger W van der Meer, Fred G J Tijl, Ellen Kapiteijn, Alexander L Vahrmeijer, Mark C Burgmans
Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer. PloS one 17 (1) (2022)
T Susanna Meijer, Mark C Burgmans
ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma. Annals of surgical oncology 27 (Suppl 3) (2020)
T Susanna Meijer, Mark C Burgmans, Eleonora M de Leede, Lioe-Fee de Geus-Oei, Bas Boekestijn, Henricus J M Handgraaf, Denise E Hilling, Jacob Lutjeboer, Jaap Vuijk, Christian H Martini, Arian R van Erkel, Rutger W van der Meer, Fred G J Tijl, Frank M Speetjens, Ellen Kapiteijn, Alexander L Vahrmeijer
Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study. Annals of surgical oncology 28 (2) (2020)
T Susanna Meijer, Mark C Burgmans, Marta Fiocco, Lioe-Fee de Geus-Oei, Ellen Kapiteijn, Eleonora M de Leede, Christian H Martini, Rutger W van der Meer, Fred G J Tijl, Alexander L Vahrmeijer
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial. Cardiovascular and interventional radiology 42 (6) (2019)

T Susanna Meijer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

T Susanna Meijer